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Abstract

DEVELOPING C. ELEGANS AS A MODEL TO STUDY TYPE 2 DIABETES
MELLITUS
By Jheesoo Ahn, M.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Masters of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2014.
Director: Young-Jai You, Ph.D.

Caenorhabditis elegans has been studied as a model organism in various areas of
biomedical research because it shares many conserved functions at molecular and genetic
levels with humans. Specifically, it is an ideal organism to study heterogeneous metabolic
syndromes such as Type 2 Diabetes Mellitus (T2DM) as C. elegans can be used to
delineate molecular pathways that are at the core of its problems. A growing number of
populations worldwide are faced with chronic T2DM, which also manifests several
complications, such as blindness, neuropathy and cardiovascular diseases. Currently,
metformin is the first-line drug of choice administered to treat T2DM. While the
mechanism by which it alleviates the symptoms of diabetes is unknown, it has been found
to reduce metabolic rate by partially inhibiting the mitochondrial complex I in mammals.
Using C. elegans as a genetic model organism, we show that metformin reduces the
viii

mitochondrial activity through endosomal Na+/H+ exchanger, which a previous lab member
has found to be a potential target of metformin. Furthermore, we show that high glucose
diet−known to reduce the worm’s lifespan−alter the endosomal-lysosomal system and
autophagy, providing insights to using C. elegans as a diabetic model. Based on these
results, we propose that C. elegans can serve as a model organism to study T2DM as well
as provide new ways to further investigate the pathophysiology of this disease.
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1. Introduction
1.1 Type 2 Diabetes Mellitus
Diabetes is one of the most prevalent diseases today affecting people worldwide,
where an estimated 382 million people have been diagnosed with diabetes in 2013. The
number is expected to reach 592 million people by the year 20351. Its economic burden has
also been increasing, as the total estimated cost of diagnosed diabetes in 2012 was $245
billion, which was a 41% increase from the estimated cost of $174 billion in 2007. These
factors are two of many which highlight the burden it creates on our society in addition to
reduced quality of life, suffering of people with diabetes, their families and friends2. Type
2 diabetes mellitus (T2DM) is the most common of the two types. T2DM is characterized
by insulin resistance and glucose intolerance3. As a result, individuals with T2DM display
both hyperinsulinemia and hyperglycemia3. Throughout the years, there have been many
advances in T2DM research, which have elucidated pathways like translocation of GLUT4
transporters in presence of insulin and subsequent glucose uptake4. Even though we have
made significant numbers of discoveries on the pathophysiology of this disease, we are
still left with no known cure. Hence, we aim to generate a simple genetic model to further
characterize its pathophysiology using Caenorhabditis elegans.
1.2 Metformin
Metformin (1,1-dimethylbiguanide) is a biguanide that is used as a first-line drug of
choice for the treatment of type 2 diabetes mellitus6. Its main function is to suppress
1

glucose production by the liver and restore insulin sensitivity in the peripheral tissues,
perhaps secondarily to the reduction in glucose concentration. Yet, this has added attention
to studying metformin’s beneficial effect on other insulin-related diseases such as
polycystic ovary syndrome, certain cancers and neurological disorders 7,3. The current view
of its actions is that once it is taken up via organic cation transporter (OCT) 1 or 2 (mainly
expressed in the liver and kidney, respectively), it then targets the mitochondrion, where it
partially inhibits complex I of the electron transport chain (ETC). It is known that the drug
inhibits complex I without affecting subsequent steps of the mitochondrial machinery and
induce a decrease in NADH oxidation, proton pumping across the inner mitochondrial
membrane and oxygen consumption rate. These sequential effects lead to the reduction of
the proton gradient and proton-driven synthesis of ATP from ADP and inorganic
phosphate (Pi)8. Consequently, the cell’s AMP/ATP ratio increases leading to the
activation of AMP-activated protein kinase (AMPK) pathway, reducing gluconeogenic
gene expression and energy consuming processes such as lipogenesis and fatty acid and
protein synthesis7. Metformin has also shown to work in a mitochondria-independent
manner through antagonistic action on the glucagon signaling pathway. This mechanism
involves AMP build-up and inhibition of adenylate cyclase activity, leading to a reduction
in cyclic adenosine monophosphate (cAMP) levels, thereby, inhibiting protein kinase A
(PKA) activity and glucagon-dependent glucose production in mice7. Despite these two
compelling lines of evidence of metformin’s actions, its mode of action still remains
unclear due to its pleotropic effects7. This brought up questions about how metformin
mediates its actions in two completely distinct pathways and what its molecular targets are.
2

Our previous work with metformin has directed our attention on the role of the endocytic
pathway upstream of the mitochondrion. Our lab has discovered that metformin targets an
endosomal Na+/H+ exchanger (NHE) in C. elegans and similar results have been shown
with Drosophila melanogaster and mammalian cells.
1.3 Na+/H+ exchanger
In C. elegans, metformin (100mM) induces increase in median lifespan under fed
conditions due to changes in folate and methionine metabolism in the bacterial food9,10;
however, it decreases the first stage larva’s (L1’s) lifespan in the absence of food, reducing
their survival from approximately 14 days to 7 days at 20°C (Figure 1). Using this
metformin sensitive phenotype, our lab performed an unbiased genetic screen for mutants
resistant to metformin and identified a mutation in the nhx-5 gene. The C. elegans genome
contains nine NHEs, NHX-1 through NHX-9, all of which exchange vesicular or
extracellular sodium for an intracellular proton11. Some are expressed on the plasma
membrane of cells, while others are expressed on the membranes of intracellular organelle.
NHX-5 is expressed on intracellular endosomes11. Our finding suggested that metformin
could potentially target NHX-5 and could be regulating the endocytic cycle. Proper
regulation of the endocytic cycle is essential for the cell’s pH homeostasis as well as for
metabolic processes such as mTOR activation and life span12,13. Putting these pieces of
evidence together, we further investigated the role of NHX-5 in the regulation of the
endocytic cycle in C. elegans.
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Figure 1
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Figure 1. Metformin reduces L1 longevity in an nhx-5 dependent manner.
Metformin (100 mM, ●) reduces L1 longevity in wild type. The nhx-5 mutant is resistant
to metformin (●). p < 0.001 between metformin treated wild type and metformin treated
nhx-5 mutant by log rank test.
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1.4 The endocytic cycle in C. elegans
NHX-5, as a potential target of metformin, led us to investigate the role of NHX-5
in the endocytic cycle. The best-studied endocytosis pathway in worms is the clathrincoated pit pathway14. Once clathrin-coated pits are formed and pinched off from the
plasma membrane, these vesicles are uncoated and fused with early endosomes in a
reaction requiring the small GTPase Rab 5. There are recycling endosomes, which
transport receptors back to the plasma membrane, whereas some materials from the
extracellular space are transported from early to late endosomes and eventually to
lysosomes for degradation (Figure 2)14. Lysosome-related organelles (LROs), also known
as gut granules in C. elegans, are acidified compartments that contain acid hydrolases and
share the functions of the classical lysosome15.
Autophagy involves induction, sequestering of cytoplasmic cargoes, nucleation and
elongation of a double-membrane organelle, the autophagosome, followed by degradation
of internalized products3. Autophagosomes, which are crucial compartments in catabolism,
are an interrelated part of the endosomal-lysosomal system because autophagosomes fuse
with the lysosome for degradation at the end of the autophagy process. In the absence of
lysosomal degradation, autophagy does not progress normally and results in pathologic
accumulation of autophagic vesicles (AVs), misfolded proteins and abnormal organelles3.
With these known facts and conserved pathways in C. elegans, we further investigated the
major compartments of the endocytic cycle as well as autophagy to study their roles in
diabetes, in addition to the role of NHX-5 in the regulation of the endocytic cycle.

6

Figure 2
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Figure 2. General model of the endocytic pathway in C. elegans (from Grant et al,
2006).
“Cargo molecules are endocytosed and targeted to early endosomes. Some cargos are
further transported to lysosomes through late endosomes. Others are recycled back to the
plasma membrane via the recycling pathway.”
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1.5 Caenorhabditis elegans as a model organism
Caenorhabditis elegans was first proposed as a model organism back in the 1960s
by Sydney Brenner as an ideal organism to study genetic and molecular mechanisms
fundamental to more complex nervous and behavioral systems of higher organisms16.
Thereafter, C. elegans has been further used for studying metabolism, reproduction, aging
and other physiological processes, providing useful knowledge of the biology and
molecular pathways underpinning human diseases. With this in mind, we aim to establish a
new diabetes model in C. elegans to further characterize the pathophysiology of the
disease. To be used as a model, C. elegans has to have conserved cellular processes and
pathways that can be targeted by metformin. Indeed, our studies with metformin and
others’ studies have shown that there are known human-to-worm conserved pathways and
cellular processes such as insulin signaling (insulin/IGF-1), AMPK/mTOR pathways and
the endocytic cycle17. More importantly, this organism will enable us to test the drug’s
effect in vivo, which could be a challenge in mammalian systems. We first demonstrate
that C. elegans displays the same physiological effect with treatment of metformin as it
does in the mammalian systems. Furthermore, we show that glucose can mimic a diabetic
condition in C. elegans. Finally, we developed transgenic worms to study the major
components of the endocytic cycle to investigate whether misregulation of the endocytic
cycle is a key pathophysiology of diabetes. My study shows that C. elegans can be a valid
model to study T2DM to advance towards finding a cure for this disease.

9

2. Results
2.1 Metformin disrupts mitochondrial function in an nhx-5 dependent manner.
When hatched in the absence of food, the first stage larvae (L1s) of C. elegans
survive starvation for approximately 14 days. Our lab previously showed that metformin
(100mM) reduces L1 longevity to 7 days (Figure 1). Metformin has been known to inhibit
mitochondrial complex I in mice and decrease lifespan in D. melanogaster6. Hence, to
better understand what effect metformin has on C. elegans, we used a whole-worm oxygen
consumption assay. First, we followed an established protocol for preparing eggs for this
experiment to synchronize the developmental stages of worms27. Synchronizing worms
was critical for the later step when we needed thousands of young adults in the same stage
for the assay. We then incubated the eggs overnight at 20°C on a rocker to allow the eggs
to hatch in nutrient-free medium and arrest at L1. We recorded the oxygen level for 7 min
and the rate of consumption was quantified as the slope of the best-fit-line between 30 sec
and 5 min 30 sec (Figure 3). The oxygen consumption rate decreased approximately 1.5
fold in wild type with the metformin treatment (Figure 4). This indicated that metformin
reduced the respiration rate significantly by reducing the mitochondrial activity18. We then
measured the oxygen consumption levels of the nhx-5(ok644) to see if metformin’s
lowering effect on respiration rate was mediated in part through NHX-5. Metformin
treatment did not change the oxygen consumption rate of nhx-5 (Figure 5); hence, we
failed to detect metformin’s effect on nhx-5.
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Figure 3. Representative graph of O2 view and best line-of-fit.
One representative graph of one wild-type sample shows how the rate was measured. The
negative slope represents worms’ oxygen consumption as a function of time. The slope
gives the rate in nmol/ml/min. The slope is always negative; therefore, we took the
absolute values of the rates and used these values to make comparisons among the samples.
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Figure 4

13

Figure 4. Metformin affects mitochondrial function in wild type.
In wild type, the oxygen consumption rate decreased significantly by approximately 1.5
fold with metformin treatment. Approximately 3000 worms were treated with 100 mM
metformin for 30 min. Each experiment was repeated at least three times. Error bars
indicate standard error of the mean. * p <0.05 by paired student’s t-test.
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Figure 5

15

Figure 5. Metformin has no effect on nhx-5 deletion mutant.
In the nhx-5 mutant, oxygen consumption rate did not change with metformin treatment.
Approximately 3000 worms were treated with 100 mM metformin for 30 min. Each
experiment was repeated at least three times. Error bars indicate standard error of the
mean. N.S.= Not Significant by paired student’s t-test.
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Interestingly, the basal rate of oxygen consumption in the nhx-5 mutant was much lower
than in the wild type. This may be due to the nature of the nhx-5 mutation, where the
deletion itself caused a decrease in oxygen consumption by altering other cellular
processes. Nonetheless, results from the assay suggested that NHX-5, at least in part, was
responsible for mediating metformin’s action on the mitochondrial activity and, therefore,
respiration rate in C. elegans.
2.2 Metformin disrupts autophagy in C. elegans.
Next, we asked how metformin reduces L1 longevity under starvation. We
hypothesized that metformin reduces L1 longevity through autophagy mainly due to
misregulation of endocytic cycle. Autophagy is a tightly controlled mechanism that
provides energy essential for survival of the organism. We examined autophagy as a
potential target of metformin’s harmful effects for two reasons. (1) We have shown that
during L1 starvation, an optimum level of autophagy is critical for the worm’s
survival19(Figure 6) (2) Our previous results suggest that metformin interferes with the
endocytic cycle through NHX-5. As mentioned above in the introduction,
autophagosomes fuse with lysosomes to degrade their contents. Thus, altering the
endocytic cycle will also alter lysosomal function and potentially affect autophagy. To
test our hypothesis, we used a transgenic worm that carries an integrated line of
GFP::LGG-1. LGG-1 encodes the C. elegans ortholog of mammalian LC3 and yeast
Atg8, which are proteins required for transport and maturation of autophagosomes and
degradation of cellular components by autophagy20,21. Under normal growth conditions, it
displays diffuse cytoplasmic localization.
17

Figure 6

18

Figure 6. Model of dual autophagy in the survival of C. elegans (from Kang et al,
2008)
This model suggests that physiological levels of autophagy are critical in the survival of
C. elegans. If there are insufficient or excessive levels of autophagy, then it could
contribute to the organism’s death19.
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During starvation, however, GFP::LGG-1 shows an increase in punctate structures in the
pharyngeal muscles and hypodermal cells. We counted puncta in the pharyngeal muscle,
one of the easiest places to locate the structures in C. elegans21 (Figure 7A and B). The
number of puncta steadily increased as starvation progressed. This indicated an increase
in autophagy level to break down more of the cellular components to replenish energy.
When we compared metformin treated and non-treated worms, the difference in the
number of puncta started appearing from day 5 of starvation. Worms starved for 4 days
did have punctate staining, but did not show any significant difference in the number
regardless of metformin (Figure 8). Metformin treatment decreased the number of puncta
staining, which suggested an inhibitory effect of the treatment. As the starvation day
progressed to 7 days, an increasing number of worms looked disfigured, indicating the
toxic effect of metformin on L1 longevity shown previously in the L1 lifespan study
(Figure 1). Intriguingly, another study showed that metformin shortened the lifespan of C.
elegans cultured in the absence of E. coli strain OP50, suggesting metformin’s harmful
effect in the absence of food regardless of developmental stages10. This study, in
conjunction with our data, suggests that metformin disrupts the physiological state of
autophagy leading to shortened lifespan.
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P	
  

Figure 7. Worms show punctate structures under starvation.
These are representative pictures of worms starved for 6 days in the absence (A) and
presence of metformin (B). The arrow shows representative GFP::LGG-1 positive
punctate structures, which label both preautophagosomal and autophagosomal structures.
These were taken with a fluorescence microscope in the green fluorescence channel. The
color and brightness of both images were equally adjusted for a better representation
using Adobe Photoshop CS5 and Microsoft© Powerpoint 2011. A=Anterior, P=Posterior.
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Figure 8. Metformin decreases the level of autophagy.
Punctate structures were counted using pictures like those shown above in Figure 7. Each
bar represents the average of at least 5 worms. Error bars indicate standard error of the
mean. N.S.= Not Significant; *p < 0.05; **p < 0.01 by paired student’s t-test.
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2.3 Developing genetic tools to study changes in the endocytic cycle.
C. elegans responds to metformin with reduced oxygen consumption rates and
autophagy levels. Next, we searched for a treatment under which C. elegans we could
develop a diabetic-mimetic condition. T2DM is induced mostly by excess of nutrition
disrupting glucose and insulin homeostasis. High D-glucose diet in C. elegans has been
shown to reduce the lifespan of adult worms (Figure 9). Another study also showed that
glucose restriction increased lifespan in worms by inducing mitochondrial respiration and
oxidative stress 22. Based on these studies, we hypothesize that treating worms with high
D-glucose could mimic a diabetic state in C. elegans. We chose to examine changes in the
endocytic cycle after high glucose diet for two reasons: (1) Our genetic screens suggested
metformin targets a compartment of the endocytic cycle, which mediates traffic between
late endosomes and lysosomes and (2) my result showed that during L1 starvation,
metformin disrupted the level of autophagy, leading to poor survival of worms. These two
results suggested that one of the main pathophysiological features of diabetes may arise
due to an abnormal endocytic cycle.
We chose to use Nile red to stain the lysosome and its related organelles. Nile red,
a lipophilic dye, is a convenient way to visualize LROs easily, as it can be taken up along
with the nutrient source, E. coli15. Synchronized L1s were mounted on a plate treated with
Nile red, with or without glucose. Pictures were taken at young adult stage two days (48-50
hours) after plating. The stage of the worms was critical because LRO staining increases
dramatically after the young adult stage due to production of eggs as well as an increase in
number of LROs. LROs also have been known to stain age-related organelles15.
25

Figure 9
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Figure 9. High glucose is harmful to worms (from Lee et al, 2009).
2% D-glucose treatment reduces adult lifespan in C. elegans. There was approximately
20% decrease in lifespan in parallel with ~50% increase in glucose levels inside the
worms. 1%, 0.5%, 0.25% and 0.05% glucose decreased lifespan while 0.025% did not23.
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We saw a significant increase in the staining of wild type treated with glucose both in the
images (Figure 10A and B) as well as in quantification (Figure 11). This suggested that
LROs were altered morphologically and/or functionally.
Our previous results and the oxygen consumption data suggested that metformin
mediated its action through NHX-5. So, we tested whether nhx-5 displayed detectable
differences in Nile red staining. Interestingly, the nhx-5 showed a reduction in Nile red
staining at its basal level compared to wild type (Figure 12). This suggested that the basal
level and integrity of LROs in nhx-5 mutants were lower than in the wild type. A possible
explanation for this reduction in nhx-5 mutant LROs is that it could be due to in part
endosomal misregulation. Following these results, we generated molecular tools to
elucidate differences in morphology and/or rates in the endocytic cycle between the wild
type and nhx-5 mutant (Table 1). These tools will be used for future studies.
Based on our findings, including oxygen consumption and studying the
components of the endocytic cycle, I propose a diabetes model, which suggests a
misregulation, which could in part explain the pathophysiology of diabetes (Figure 13).
Normal regulation of the endocytic cycle leads to normal degradation and recycling
of materials in a normal state; however, in a diabetic state, there is misregulation in the
endosomal-lysosomal system. Two explanations for this are: (1) the endosome is
misregulated away from the lysosome due to pH mis-regulation, which can be caused by
the nhx-5 mutant and (2) the endosome fuses with the lysosome, but fusion does not cause
degradation because the lysosomal pH is not optimized for proper enzymatic breakdown.
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Figure 10. Nile Red stains lysosome-related organelles.
Representative pictures of Nile red stained young adult worms in the absence (A) and
presence of glucose (B). The Materials and Methods section contains a detailed
explanations of how Nile red staining was done. A=Anterior; P=Posterior
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Figure 11
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Figure 11. Wild-type worms with glucose treatment show increase in LROs.
Quantification of intensities was performed using pictures like those shown above in
Figure 10. This is gathered data from six independent experiments. The total number of
worms for each condition is indicated above. Error bars indicate standard error of the
mean. *p < 0.05 by paired student’s t-test. A.U.= Arbitrary Unit.
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Figure 12
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Figure 12. nhx-5 mutants show lower basal level of LROs compared to the wild-type.
There was a decrease in Nile red intensities in the nhx-5 deletion mutant compared to the
wild-type. Approximately 20-30 worms were quantified for each strain and the
experiment was repeated at least three times. Error bars indicate standard error of the
mean. ***p < 0.001 by paired student’s t-test. A.U.= Arbitrary Unit.
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Figure 13
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Figure 13. A proposed diabetes model.
This model shows a simplified version of a diabetic model from our studies. In wild type,
there is a normal regulation of the endocytic cycle and autophagy, leading to orderly
degradation of materials. In a diabetic state, there is misregulation of the endocytic cycle
and autophagy. We speculate that 1) Endosomal pH is not modulated to its optimal pH
leading to its mistrafficking away from the lysosome. 2) The endosome fuses with the
lysosome, but the lysosome cannot degrade materials because pH is not optimal for
protease activation. When the endosome-lysosome network starts to be misregulated,
autophagy will be affected because degradation of materials in the autophagosome requires
fusion with lysosome in the final step.

36

This leads to an enlargement and/or increase in number of lysosomal vesicles, which is
also in part explained by our glucose treatment experiment. While the autophagosome is
not directly regulated by endosome, the final degradative process is dependent on the
endosomal-lysosomal system. If this system breaks down, then it is most likely that
autophagy will also be impeded from performing its normal functions.

37

3. Materials and Methods
C. elegans Strains and Maintenance
C. elegans variant Bristol, strain N2 was used as the wild-type. All strains were stored at
20°C and maintained on NGM plates seeded with Escherichia coli strain HB101 unless
noted otherwise. Four strains were obtained from the Caenorhabditis Genetic Center
(CGC, University of Minnesota): GH383 glo-3 (zu446), GH403 glo-3(kx94), JJ1271 glo1(zu391), CB1003 flu-2(e1003). Other strains used were YJ53 nhx-5(ok661) X and
DA2123 adIs2122[lgg-1::gfp;rol-6(gf)]. YJ53 was derived from RB836 nhx-5(ok661) by
outcrossing 3 times against N2. RB836 obtained from the CGC. Transgenic worms
carrying extra-chromosomal array were made by microinjection into N2: YJ201 [rab5::mcherry], YJ90 [ges-1p::snb-1::pHluorin] and YJ92 [rol-6p::snb-1::pHluorin].
Nile Red Staining
Prior to L1 transferring, NGM plates were layered with 600 µL of a 500 µg/mL Nile red
stock in acetone, which was made previously. Nile Red staining was quantified using the
ImageJ and WormFluorescent1 programs, in which the intensities were calculated by
subtracting the background intensity from the total intensity, multiplying the area by the
intensity above threshold, and averaging final calculation for each condition. Nile red
quantification data compiled from 20−30 per experiment.
Glucose Treatment

38

The NGM plates were treated with 100 mM D-glucose on the lawn of bacteria. Eggprepped L1 worms were plated and exposed to glucose plates for 48-50 hours before the
pictures were taken.
Quantification of Oxygen Consumption Rates
Wild type and the nhx-5 mutant YJ53 were prepared and synchronized by egg
preparation27. Synchronized L1s were grown to young adulthood for 48~50 hours at 20°C.
Young adults were collected with M9 and were resuspended in either 2 mL of 100 mM
metformin in M9 or 2 mL of buffer only (control) for 30 minutes in liquid. Oxygen
consumption rates were measured for seven minutes and normalized to the number of
worms, counted after the recording. Approximately 2000-3000 worms were used. The
experiments were performed in triplicate for each treatment and every experiment was
repeated at least three times. Oxygen consumption rates were measured using the
Hansatech Instrument Oxytherm system with S1/MINI electrode and Peltier Electrode
Chamber. The data was acquired using O2 view data acquisition and system configuration
software. A 1M stock solution of metformin (Aldrich, Catalog # D150959-5G) was
prepared prior to experiments.
Markers and Microinjections
The DNA construct of synaptobrevin-1::pHluorin was expressed in the desired location in
the worm by fusing it to specific promoters from the ges-1 and rol-6 genes using PCR
primers design by Dr. Jeongho Kim. DNA constructs were constructed prior to injection.
Microinjection needles were pulled using the laser micropipette puller system Model P2000 (Sutter Instrument). Injection was performed using an Axio Observer.A1 Zeiss
39

compound microscope, eppendorf TransferMan® NK2 micromanipulator and FemtoJet®
microinjector (Fisher Scientific).
Microscopy and Image Analysis
For Nile red analysis by differential interference microscopy (DIC) and epifluorescence,
live worms were mounted on 3% agarose pads with 50 mM Sodium Azide (NaN3). The
pictures were taken with an Axioplan2 Zeiss Imager compound microscope and AxioCam
camera with Openlab software (Improvision). Exposure time: 100 msec. Magnification:
10x. Confocal images were taken with a Zeiss LSM 700 with a 63x/1.40 Oil DIC M27
objective in single or multi-track mode using a single excitation wavelength of 488 nm for
GFP. Additional image processing was done using LSM Zen software (Carl Zeiss).
Autophagosome Count and Analysis
Worms carrying an integrated line expressing LGG-1::GFP were egg-prepped and either
incubated either in the absence or the presence of metformin (100 mM) for varing times.
They were incubated at 20°C on a rocker, and a drop of worms was mounted on an agar
pad for pictures. Approximately 5-8 images were taken per worm at different focal planes
to get a whole-worm count of the punctate structures in the pharyngeal muscles. Exposure
Time: Auto-live. Magnification: 100x Oil.
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4. Conclusions and Future Directions
C. elegans is a simple organism, yet it has provided us with great amount of
knowledge in the basic sciences, which are still critical to our understanding of the world,
ourselves and many other related phenomena. Additionally, important contributions were
made through C. elegans such as RNA interference, green fluorescent protein (GFP) and
cell death. On top of everything it has already given to the scientific community, it still
continues to be an ideal organism to study more complex issues related to human diseases
in metabolism, neurology, reproduction and behavior. Nonetheless, there is, unequivocally,
room for exploration of subjects that have not yet been studied in C. elegans.
Today, we live in a world where excessive food consumption is a commonplace. It
comes at a cost with an epidemic public health problem such as Type 2 Diabetes Mellitus
(T2DM). It is not curable to this day, but there have been significant advances in treatment
options. One of the most widely prescribed and efficient treatments is metformin. Since its
discovery, metformin has been studied extensively to elucidate its molecular target.
Understanding its target is essential to cater to the needs of patients, as T2DM is
complicated with other diseases and polymorphisms of important cellular components such
as OCT17. One of the best-understood molecular mechanisms of action of metformin is
that it partially inhibits mitochondrial complex I, thereby activating the AMPK pathway6.
To find out if this activation was conserved throughout the phyla, we wanted to test
whether metformin also inhibited respiration in C. elegans. Indeed, we saw a decrease in
oxygen consumption, which gave us a lead to subsequent experiments.
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More importantly, a broader understanding we wanted to gain from this study with
C. elegans was to examine if we could use C. elegans as a model system to study T2DM.
We know that T2DM is a complex disease influenced by environmental and genetic
factors; therefore, narrowing down on the cause of this disease to one mechanism could
answer what is really crucial in the pathogenesis of T2DM. We used metformin as a tool to
understand what it does in C. elegans both in physiological and non-physiological states.
We found that metformin decreases L1 lifespan in the starved state and significantly
inhibits the mitochondrial activity in an nhx-5 dependent manner. After these two findings,
we looked for an answer as to how metformin decreased L1 lifespan. We found that
metformin inhibited autophagy levels, which explained, in part, the detrimental affect it
had on starved L1s. Autophagy has been shown to be beneficial at its physiological level,
but in excess or insufficient levels it could cause death of an organism. The resulting
studies showed that metformin disrupted the level of autophagy. We speculate that the
inhibitory effect is due to misregulation of the endosomal-lysosomal system, since the
degradation of materials in the autophagosome requires fusion with the lysosome in its
final step. This raises the next question: is regulation of the endocytic cycle important for
the pathogenesis of T2DM and can we use C. elegans to test this?
Our previous work with metformin in C. elegans led us to discovering endosomal
NHX-5. Since then, we found that it could be an important player in mediating
metformin’s action as well as modulating the endocytic pathway. Thereafter, studies with
glucose and lysosome-related organelles showed that LROs might be dysfunctional in the
presence of high glucose. The exact mechanism by which this occurs is not clearly defined
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by our results, but we propose that it is due to the misregulation of endosomal vesicles
and/or lysosomal degradation. There is continuous cross-talk between endosomes and
lysosomes; therefore, it is important that they are regulated properly. Autophagy is also
essential to our understanding because it will indirectly depend on the integrity of the
endosomal-lysosomal system. Understanding these dynamic processes of autophagy and
endosomal-lysosomal systems is critical as many maladaptive processes of the cycle could
lead to shorter lifespan and disease states24,25,26. Endocytic vesicles as well as
autophagosomes constitute a continuous system, connecting one destination to another.
Studying these prcesses in a live system both intracellularly and in the whole-organism is a
challenge, but our study sheds some light on this dynamic process.
In this study, we examined a conserved cellular pathway in C. elegans to further
characterize the pathophysiology of T2DM. Our results suggest that the endocytic cycle
and autophagy may be an area of research for future studies related to T2DM. Such studies
could be plausibly be conducted in C. elegans; however, there are challenges that need
some insights to go beyond what we learned from this study. First and foremost, future
studies should focus on how autophagy is regulated in nhx-5 mutants. This will give us a
better understanding of autophagy regulation in relation to endosome and NHX-5.
Moreover, further studies should characterize LRO functions in the endocytic cycle to
elucidate what happens in enlarged and non-functional LROs. Last but not least, finding
solutions to monitor pH modulation in endosomes and to overcome autofluorescence will
help link these dynamic processes of endosomes to the lysosome as well as to autophagy
and mitochondria.
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APPENDIX-A
Genotype	
  
act-‐5p::	
  rab-‐5::mCherry	
  

Expression	
  
Early	
  endosome	
  
(Intestine)	
  
ges-‐1p::snb-‐1::pHluourin	
   Endosome	
  
(Intestine)	
  
rol-‐6p::snb-‐1::pHluourin	
   Endosome	
  
(Hypodermis)	
  

Purpose	
  
Experiments	
  
GTPase	
  marker	
  for	
  
✔	
  
early	
  endosomes	
  
Neutralization	
  of	
  pH	
  in	
  
✔	
  
endosomes	
  
Neutralization	
  of	
  pH	
  in	
  
✔	
  
endosomes	
  

Table 1. Tools to monitor endocytic cycle and pH changes in its compartments.
Transgenic worms were made and used for detecting organelles expressed at designated
sites. Many fluorescence pictures of these transgenic worms were taken, but since the
results were inconclusive, they were not included in this study.
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APPENDIX-B
A

Day 3 - met

A	
  
B

P	
  

Day 3 + met

A	
  

10 μm

Figure 14. Punctate structures were detectable in L1s starved for 3 days.
These are confocal images of 3 days starved L1s in absence (A) and presence of metformin
(B). They show clearer punctate structures as well as clear outlines of pharyngeal muscles
compared to the previous fluorescence images. A=Anterior; P=Posterior
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